Literature DB >> 32265710

Serum Metabolic Profiling Reveals the Antidepressive Effects of the Total Iridoids of Valeriana jatamansi Jones on Chronic Unpredictable Mild Stress Mice.

Yongbiao Li1,2, Lanlan Wu1,2, Chang Chen2, Liwen Wang1, Cong Guo2, Xiaoqin Zhao1, Tingting Zhao1,2, Xinyi Wang2, An Liu2, Zhiyong Yan1.   

Abstract

BACKGROUND: Depression is a long-term complex psychiatric disorder, and its etiology remains largely unknown. Valeriana jatamansi Jones ex Roxb (V. jatamansi) is used in the clinic for the treatment of depression, but there are insufficient reports of its antidepressive mechanisms and a poor understanding of its endogenous substance-related metabolism. The objective of this study was to identify biomarkers related to depression in serum samples and evaluate the antidepressive effects of the iridoid-rich fraction of V. jatamansi (IRFV) in a chronic unpredictable mild stress (CUMS) mouse model.
METHODS: Here, CUMS was used to establish a mouse model of depression. Behavioral and biochemical indicators were investigated to evaluate the pharmacodynamic effects. A comprehensive serum metabolomics study by nuclear magnetic resonance (NMR) approach was applied to investigate the pharmacological mechanism of IRFV in CUMS mouse. Subsequently, we used multivariate statistical analysis to identify metabolic markers, such as principal component analysis (PCA) and orthogonal projection to latent structure with discriminant analysis (OPLS-DA), to distinguish between the CUMS mouse and the control group.
RESULTS: After IRFV treatment, the immobility time, sucrose preference, and monoamine neurotransmitter were improved. PCA scores showed clear differences in metabolism between the CUMS group and control group. The PLS-DA or OPLS-DA model exhibited 26 metabolites as biomarkers to distinguish between the CUMS mice and the control mouse. Moreover, IRFV could significantly return 21 metabolites to normal levels.
CONCLUSION: The results confirmed that IRFV exerted an antidepressive effect by regulating multiple metabolic pathways, including the tricarboxylic acid cycle, the synthesis of neurotransmitters, and amino acid metabolism. These findings provide insights into the antidepressive mechanisms of IRFV.
Copyright © 2020 Li, Wu, Chen, Wang, Guo, Zhao, Zhao, Wang, Liu and Yan.

Entities:  

Keywords:  1H NMR; Valeriana jatamansi Jones; depression; iridoids; metabolomics

Year:  2020        PMID: 32265710      PMCID: PMC7099651          DOI: 10.3389/fphar.2020.00338

Source DB:  PubMed          Journal:  Front Pharmacol        ISSN: 1663-9812            Impact factor:   5.810


  70 in total

1.  Metabonomic alterations in hippocampus, temporal and prefrontal cortex with age in rats.

Authors:  Xianrong Zhang; Huilang Liu; Junfang Wu; Xu Zhang; Maili Liu; Yong Wang
Journal:  Neurochem Int       Date:  2009-02-24       Impact factor: 3.921

2.  Induction of oxidative stress by restraint stress and corticosterone treatments in rats.

Authors:  Ayesha Zafir; Naheed Banu
Journal:  Indian J Biochem Biophys       Date:  2009-02       Impact factor: 1.918

3.  Anti-depressant effects of Xiaoyaosan on rat model of chronic unpredictable mild stress: a plasma metabonomics study based on NMR spectroscopy.

Authors:  Xiao-Jie Liu; Yu-Zhi Zhou; Zhong-Feng Li; Jie Cui; Zhen-Yu Li; Xiao-Xia Gao; Hai-Feng Sun; Li-Zeng Zhang; Guan-Hua Du; Xue-Mei Qin
Journal:  J Pharm Pharmacol       Date:  2011-12-29       Impact factor: 3.765

4.  Adverse emotional and interpersonal effects reported by 1829 New Zealanders while taking antidepressants.

Authors:  John Read; Claire Cartwright; Kerry Gibson
Journal:  Psychiatry Res       Date:  2014-02-03       Impact factor: 3.222

Review 5.  Thyroid peroxidase autoantibodies and perinatal depression risk: A systematic review.

Authors:  Manish Dama; Meir Steiner; Ryan Van Lieshout
Journal:  J Affect Disord       Date:  2016-03-09       Impact factor: 4.839

6.  Major depression in the national comorbidity survey-adolescent supplement: prevalence, correlates, and treatment.

Authors:  Shelli Avenevoli; Joel Swendsen; Jian-Ping He; Marcy Burstein; Kathleen Ries Merikangas
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2014-10-29       Impact factor: 8.829

7.  Anxiolytic-like effects of compound zhi zhu xiang in rats.

Authors:  Yan-Li Wang; Jin-Li Shi; Liu Yong; Zhao Ren; Yu-Jing Zhai; Jian-You Guo
Journal:  Evid Based Complement Alternat Med       Date:  2012-05-29       Impact factor: 2.629

8.  Development of an Optimized Protocol for NMR Metabolomics Studies of Human Colon Cancer Cell Lines and First Insight from Testing of the Protocol Using DNA G-Quadruplex Ligands as Novel Anti-Cancer Drugs.

Authors:  Ilaria Lauri; Francesco Savorani; Nunzia Iaccarino; Pasquale Zizza; Luigi Michele Pavone; Ettore Novellino; Søren Balling Engelsen; Antonio Randazzo
Journal:  Metabolites       Date:  2016-01-15

9.  Challenge and Prospect of Traditional Chinese Medicine in Depression Treatment.

Authors:  Yuan-Wei Zhang; Yung-Chi Cheng
Journal:  Front Neurosci       Date:  2019-03-05       Impact factor: 4.677

10.  Metabolomic signatures and microbial community profiling of depressive rat model induced by adrenocorticotrophic hormone.

Authors:  Jing Song; Weini Ma; Xinyi Gu; Le Zhao; Jiaye Jiang; Ying Xu; Lei Zhang; Mingmei Zhou; Li Yang
Journal:  J Transl Med       Date:  2019-07-15       Impact factor: 5.531

View more
  6 in total

1.  Disturbance of neurotransmitter metabolism in drug-naïve, first-episode major depressive disorder: a comparative study on adult and adolescent cohorts.

Authors:  Liwei Wang; Ping Yang; Chao Yang; Dong Yang; Xiangxin Wu; Ting Cao; Cuirong Zeng; Qian Chen; Shuangyang Zhang; Zhenyu Zhu; Shimeng Jiao; Hualin Cai
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2022-04-11       Impact factor: 5.760

2.  The Combination of Aquilaria sinensis (Lour.) Gilg and Aucklandia costus Falc. Volatile Oils Exerts Antidepressant Effects in a CUMS-Induced Rat Model by Regulating the HPA Axis and Levels of Neurotransmitters.

Authors:  Huiting Li; Yuanhui Li; Xiaofei Zhang; Guilin Ren; Liangfeng Wang; Jianzhe Li; Mengxue Wang; Tao Ren; Yi Zhao; Ming Yang; Xiaoying Huang
Journal:  Front Pharmacol       Date:  2021-02-24       Impact factor: 5.810

Review 3.  Plant Species of Sub-Family Valerianaceae-A Review on Its Effect on the Central Nervous System.

Authors:  Gitishree Das; Han-Seung Shin; Rosa Tundis; Sandra Gonçalves; Ourlad Alzeus G Tantengco; Maria G Campos; Rosaria Acquaviva; Giuseppe Antonio Malfa; Anabela Romano; Joyce Ann H Robles; Mariel Q Clores; Jayanta-Kumar Patra
Journal:  Plants (Basel)       Date:  2021-04-22

4.  Spectrum-Efficacy Relationships between GC-MS Fingerprints of Essential Oil from Valerianae Jatamansi Rhizoma et Radix and the Efficacy of Inhibiting Microglial Activation.

Authors:  Nan-Yun Yang; Qi-Rui Li; Xu Zhang; Fan-Li Zeng; Xiang-Chun Shen; Qing-De Long
Journal:  Evid Based Complement Alternat Med       Date:  2022-03-07       Impact factor: 2.629

Review 5.  The potential of Valeriana as a traditional Chinese medicine: traditional clinical applications, bioactivities, and phytochemistry.

Authors:  Jianchun Li; Xiaoliang Li; Changfu Wang; Manli Zhang; Minhui Ye; Qiuhong Wang
Journal:  Front Pharmacol       Date:  2022-09-21       Impact factor: 5.988

6.  Antidepressant effects of total iridoids of Valeriana jatamansi via the intestinal flora-blood-brain barrier pathway.

Authors:  Li Zhang; Liwen Wang; Li Huang; Yanni Zhao; Hongling Ding; Binglong Li; Lingmiao Wen; Wei Xiong; Yanjun Liu; Tinglan Zhang; Liudai Zhang; Lanlan Wu; Qing Xu; Yuqing Fan; Guihua Wei; Qiaozhi Yin; Yunhui Chen; Tiane Zhang; Zhiyong Yan
Journal:  Pharm Biol       Date:  2021-12       Impact factor: 3.503

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.